BPC-157 is classified as a pentadecapeptide , and it works by accelerating the bodys natural repair processes
The human dopamine transporter (hDAT) contains a high-affinity, extracellular, and allosteric Zn 2+ (zinc ion) binding site which, upon zinc binding, inhibits dopamine reuptake, inhibits amphetamine-induced hDAT internalization, and amplifies amphetamine-induced dopamine efflux
These studies suggest oxidative stress affects viral infection by directly regulating viral survival or indirectly affecting virus infection via apoptosis and autophagy
In some embodiments, the steady state concentration of an active agent released from a controlled-release otic formulation described herein is from about 20 to about 50 times the steady state concentration of an active agent released from a formulation that is not a controlled-release otic formulation
A basis for illegal performance enhancement